**Core Concept:** Lithium is a medication primarily used in the treatment of bipolar disorder. It is an effective mood stabilizer, but its use can lead to various side effects, including fetal malformations when taken by pregnant women. Lithium crosses the placenta and can interfere with normal fetal development, resulting in congenital anomalies.

**Why the Correct Answer is Right:** Lithium is known to cause a range of fetal malformations due to its teratogenic effects. One such congenital anomaly associated with lithium therapy is the development of a cleft lip and palate in the fetus. This is because lithium alters the normal growth and differentiation of the facial structures, leading to the formation of cleft lip and palate.

**Why Each Wrong Option is Incorrect:**

A. **Congenital Hypothyroidism:** Lithium does not cause congenital hypothyroidism, which is a hormonal disorder resulting from thyroid gland dysfunction. The teratogenic effects of lithium are specific to facial structure development, not thyroid function.

B. **Hypercalcemia:** Lithium can cause hypercalcemia (high blood calcium levels), but it does not lead to congenital anomalies like cleft lip and palate. The teratogenic effects of lithium are distinct from its hypercalcemic effects.

C. **Hypocalcemia:** Lithium can cause hypocalcemia (low blood calcium levels) but does not result in cleft lip and palate. The teratogenic effects of lithium are specific to facial structure development, not calcium homeostasis.

D. **Increased Risk of Autism Spectrum Disorder:** Lithium therapy does not specifically increase the risk of autism spectrum disorder. The teratogenic effects of lithium are specific to cleft lip and palate, not autism.

**Clinical Pearl:** In clinical practice, this understanding of lithium's specific teratogenic effects helps guide counseling of patients on potential risks during pregnancy. Pregnant women taking lithium should be informed about the increased risk of cleft lip and palate in their offspring, which is one of the reasons to discontinue lithium therapy in women planning or during pregnancy.